Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

Your Blueprint for Flawless Pharma Omnichannel

October 9, 2025 | Advisory Boards, Impetus Digital, MSL enablement, Product Launches, omni-channel, omnichannel, omnichannel strategy, omnichannel webinar, pharma omnichannel, pharma webinar, unified omnichannel, webinar 

Learn how to eliminate silos, transform data into actionable insights, and drive unparalleled efficiency across your key initiatives. Secure your spot in our free webinar, exclusive for life science professionals!

- PMLiVE

Tired of a fragmented omnichannel strategy that falls short of its promise? Join Impetus Digital’s complimentary, pharma-exclusive webinar, “A Blueprint for Unified Omnichannel in Pharma,” to learn how to move beyond basic touchpoints and deliver seamless, intelligent impact across every interaction. Get the proven blueprint to eliminate silos, transform fragmented data into actionable insights, and achieve unparalleled operational efficiency across key initiatives like advisory boards, MSL enablement, and product launches. Register today to unlock the full potential of your omnichannel strategy.

Register Now

This content was provided by Impetus Digital

Company Details

- PMLiVE

Impetus Digital

Email
Website

 Latest Content from  Impetus Digital 

Tailored Marketing Strategies for Pharma – Top 10 Most Important Advisor Questions

In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today’s diverse healthcare landscape. 7….

Trends in Virtual Collaboration

Join us for a look at the top-5 emerging virtual collaboration trends…

Advisor Questions on Potential Data or Knowledge Gaps

As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here’s another one to keep in…

On a journey to diverse, inclusive, and more efficient rare disease trials

Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care…

Versatility! Top 10 benefits of virtual advisory boards

Here’s another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #10. Versatility! Another major advantage of using a virtual platform…

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story

In the early lead-up to our client’s multi-center Rare Disease Phase 3 Clinical Trial, they first conducted an internal engagement planning Longitudinal Expert Engagement Plan™ (LEEP™) to conduct an informal…

New Playbook Alert: Virtual Patient Engagement

Authentic patient engagement and insight-gathering are becoming must-haves in Pharma. However, multiple obstacles remain before patient-centricity becomes more than a buzzword. In our latest playbook, we take a deep dive…

No “White Space” Between Live Meetings; the top 10 benefits of virtual advisory boards

Here’s another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #9. No More “White Space” Between Live Meetings Clearly, the…

The problem with clinical trials (and how virtual insight-gathering can help)

While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access.

Ease and Effectiveness of Knowledge Sharing; the top 10 benefits of virtual advisory boards

Here’s another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #8. The Ease and Effectiveness of Sharing Knowledge and Data…